EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The National Cancer Institute clinical trials planning meeting to address gaps in observational and intervention trials for cancer-related cognitive impairment

Michelle C Janelsins iD, Kathleen Van Dyk iD, Sheri J Hartman, Thuy T Koll, Christina K Cramer, Glenn J Lesser, Debra L Barton, Karen M Mustian, Lynne I Wagner, Patricia A Ganz, Peter D Cole, Alexis Bakos und 23 weitere

JNCI: Journal of the National Cancer Institute · 01.02.2025 · 117 (2) · 217-228

DOI: 10.1093/jnci/djae209 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JNCI: Journal of the National Cancer Institute, online erschienen am 09.09.2024. Verfasst von Michelle C Janelsins und 34 weiteren Autor:innen. Beteiligte Einrichtung: Division of Supportive Care in Cancer, Department of Surgery, University of Rochester Medical Center, Wilmot Cancer Institute, Rochester, NY, USA. Hauptthemen laut MEDLINE: Neoplasms, Cognitive Dysfunction, Clinical Trials as Topic. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NIA NIH HHS, NCI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer-related cognitive impairment is a broad term encompassing subtle cognitive problems to more severe impairment. The severity of this impairment is influenced by host, disease, and treatment factors, and the impairment affects patients before, during, and following cancer treatment. The National Cancer Institute (NCI) Symptom Management and Health-Related Quality of Life Steering Committee (SxQoL SC) convened a clinical trial planning meeting to review the state of the science on cancer-related cognitive impairment and develop phase II/III intervention trials aimed at improving cognitive function in cancer survivors with non–central nervous system disease and longitudinal studies to understand the trajectory of cognitive impairment and contributing factors. Participants included experts in the field of cancer-related cognitive impairment, members of the SxQoL SC, patient advocates, representatives from all 7 NCI Community Oncology Research Program research bases, and the NCI. Presentations focused on the following topics: measurement, lessons learned from pediatric and geriatric oncology, biomarker and mechanism endpoints, longitudinal study designs, and pharmacological and behavioral intervention trials. Panel discussions provided guidance on priority cognitive assessments, considerations for remote assessments, inclusion of relevant biomarkers, and strategies for ensuring broad inclusion criteria. Three clinical trial planning meeting working groups (longitudinal studies as well as pharmacological and behavioral intervention trials) convened for 1 year to discuss and report on top priorities and to design studies. The meeting experts concluded that sufficient data exist to advance phase II/III trials using selected pharmacological and behavioral interventions for the treatment of cancer-related cognitive impairment in the non–central nervous system setting, with recommendations included herein.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsCognitive DysfunctionClinical Trials as TopicHumansNational Cancer Institute (U.S.)United StatesResearch DesignQuality of LifeObservational Studies as Topic

Autor:innen und Institutionen

  • Division of Supportive Care in Cancer, Department of Surgery, University of Rochester Medical Center, Wilmot Cancer Institute, Rochester, NY, USA.
  • Department of Psychiatry, David Geffen Scholl of Medicine, Semel Institute for Neuroscience and Human Behavior, University of California Los Angeles, Los Angeles, CA, USA.
  • Herbert Wertheim School of Public Health and Human Longevity Science, University of California, San Diego, San Diego, CA, USA.
  • Division of Geriatrics, Gerontology and Palliative Medicine, Department of Medicine, University of Nebraska Medical Center, Omaha, NE, USA.
  • Department of Radiation Oncology, Wake Forest University School of Medicine, Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC, USA.
  • Department of Internal Medicine, Section on Hematology and Oncology, Wake Forest University School of Medicine, Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC, USA.

ORCID-Profile: Michelle C Janelsins, Kathleen Van Dyk, James C Root, Allison Magnuson, Andrew J Saykin, Jeffrey S Wefel, Donald Mabbott

Förderung

  • NCI NIH HHS
  • NIA NIH HHS
  • NCI
  • NIH HHS
  • HHS
  • Department of Health and Human Services
  • National Institutes of Health

Zitieren

APA

Janelsins, M. C., Van Dyk, K., Hartman, S. J., Koll, T. T., Cramer, C. K., Lesser, G. J., Barton, D. L., Mustian, K. M., Wagner, L. I., Ganz, P. A., Cole, P. D., Bakos, A., Root, J. C., Hardy, K., Magnuson, A., Ferguson, R. J., McDonald, B. C., Saykin, A. J., Gonzalez, B. D., …, & Dorsey, S. G. (2025). The National Cancer Institute clinical trials planning meeting to address gaps in observational and intervention trials for cancer-related cognitive impairment. JNCI: Journal of the National Cancer Institute, 117(2), 217-228. https://doi.org/10.1093/jnci/djae209

Vancouver

Janelsins MC, Van Dyk K, Hartman SJ, Koll TT, Cramer CK, Lesser GJ, et al. The National Cancer Institute clinical trials planning meeting to address gaps in observational and intervention trials for cancer-related cognitive impairment. JNCI: Journal of the National Cancer Institute. 2025;117(2):217-228. doi:10.1093/jnci/djae209

BibTeX
@article{Janelsins2025,
  author = {Janelsins, Michelle C and Van Dyk, Kathleen and Hartman, Sheri J and Koll, Thuy T and Cramer, Christina K and Lesser, Glenn J and Barton, Debra L and Mustian, Karen M and Wagner, Lynne I and Ganz, Patricia A and Cole, Peter D and Bakos, Alexis and Root, James C and Hardy, Kristina and Magnuson, Allison and Ferguson, Robert J and McDonald, Brenna C and Saykin, Andrew J and Gonzalez, Brian D and Wefel, Jeffrey S and Morilak, David A and Dahiya, Saurabh and Heijnen, Cobi J and Conley, Yvette P and Morgans, Alicia K and Mabbott, Donald and Monje, Michelle and Rapp, Stephen R and Gondi, Vinai and Bender, Catherine and Embry, Leanne and McCaskill Stevens, Worta and Hopkins, Judith O and St Germain, Diane and Dorsey, Susan G},
  title = {The National Cancer Institute clinical trials planning meeting to address gaps in observational and intervention trials for cancer-related cognitive impairment},
  journal = {JNCI: Journal of the National Cancer Institute},
  year = {2025},
  volume = {117},
  number = {2},
  pages = {217--228},
  doi = {10.1093/jnci/djae209}
}
Kostenlos starten →